MAY 07, 2020 6:16 AM PDT

New COVID-19 Vaccine Defends Monkeys Against Infection

WRITTEN BY: Tara Fernandez

Researchers from Beijing-based Sinovac Biotech have reported preliminary results of a study into the development of a vaccine against COVID-19. This is some of the first evidence of a vaccine showing efficacy in a primate experimental model (rhesus macaques) and provides hope for a global community anxiously awaiting countermeasures against the escalating pandemic.

Experts estimate that a clinically-available vaccine against SARS-CoV-2 could take 18 months or longer to develop, even at an accelerated pandemic pace. A new vaccine needs to be thoroughly tested for safety and efficacy in animals and humans prior to its commercialization. Before phase I testing, in which a small group of healthy volunteers receives the vaccine in development, vaccines are typically tested in non-human primates, which share physiological and disease process similarities with humans.

In Sinovac’s study, the vaccine testing protocol involved two doses of inactivated SARS-CoV-2, administered to a cohort of eight rhesus monkeys. The animals were allowed to develop a natural immune response to the inactivated virus over the course of three weeks. They were then exposed to live, unadulterated SARS-CoV-2 to test the protective capabilities of the vaccine treatment.

Encouragingly, none of the monkeys experienced the symptoms of severe infection, nor had any unwanted side-effects as a result of the shot. Meanwhile, the control animals developed pneumonia and high levels of circulating virus as a result of exposure to the coronavirus.

In response to these findings, Florian Krammer, a virologist based at the  Icahn School of Medicine at Mount Sinai said, “This is old school but it might work. What I like most is that many vaccine producers, also in lower–middle-income countries, could make such a vaccine.”

While promising, experts warn that preclinical validation of a new vaccine will involve much more work: larger testing cohorts to provide statistical significance and testing protection against viral strains that specifically infect humans and escape variant strains.

Sinovac has already launched phase I human trials of its vaccine in China to evaluate the safety and degree of protection in over 100 volunteers. If these clinical trials go as planned, phase II studies will kick off in mid-May in a larger group of over 1,000 individuals.

 


Source: Science.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 10, 2020
Drug Discovery & Development
Injection 66% Better than Daily Pill to Prevent HIV
JUL 10, 2020
Injection 66% Better than Daily Pill to Prevent HIV
Pharmaceutical company ViiV Healthcare has announced that its long-lasting, injectable drug, cabotegravir, is more effec ...
JUL 19, 2020
Drug Discovery & Development
Study Finds Turmeric has Antiviral Effects
JUL 19, 2020
Study Finds Turmeric has Antiviral Effects
Researchers from the Wuhan University of Engineering in China have found that curcumin, a natural compound found in turm ...
JUL 21, 2020
Immunology
Hormone Therapies Keep Urinary Tract Infections at Bay
JUL 21, 2020
Hormone Therapies Keep Urinary Tract Infections at Bay
More than half of all women will suffer from a urinary tract infection, or UTI, during their lifetimes. Women are consid ...
JUL 23, 2020
Immunology
Cancer Therapy Reduces Lung Scarring
JUL 23, 2020
Cancer Therapy Reduces Lung Scarring
Scientists at the Stanford Institute for Stem Cell Biology and Regenerative Medicine have discovered a striking parallel ...
SEP 17, 2020
Immunology
COVID Vaccine Works in Macaques - What about in Humans?
SEP 17, 2020
COVID Vaccine Works in Macaques - What about in Humans?
Pharmaceutical giant Pfizer, in partnership with BioNTech has reported that one of its lead vaccine candidates has shown ...
OCT 11, 2020
Microbiology
Getting Closer to a Vaccine for Flaviviruses
OCT 11, 2020
Getting Closer to a Vaccine for Flaviviruses
Flaviviruses like dengue, West Nile, Zika, Japanese Encephalitis, and yellow fever infect over 400 million people a year ...
Loading Comments...